Tags

Type your tag names separated by a space and hit enter

The cost of unsafe injections.
Bull World Health Organ. 1999; 77(10):808-11.BW

Abstract

Unsafe injection practices are associated with substantial morbidity and mortality, particularly from hepatitis B and C and human immunodeficiency virus (HIV) infections. These inadvertently transmitted bloodborne diseases become manifest some considerable time after infection and hence may not be appropriately accounted for. Annually more than 1.3 million deaths and US$ 535 million are estimated to be due to current unsafe injection practices. With the global increase in the number of injections for vaccination and medical services, safer injecting technologies such as auto-disable syringes must be budgeted for. Investment in health education and safer disposal will also reduce infections associated with unsafe injecting practices. Safer injecting practices are more expensive than current less safe practices, but the additional cost is more than offset by the reduction in disease that would result.

Links

PMC Free PDF
PMC Free Full Text

Authors+Show Affiliations

Miller MA
Children's Vaccine Initiative, Geneva, Switzerland. millermark@who.ch
Pisani E
No affiliation info available

MeSH

Cross InfectionForecastingGlobal HealthHIV InfectionsHealth Care CostsHepatitis BHepatitis CHumansIncidenceInjectionsMorbidity

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

10593028

Citation

Miller, M A., and E Pisani. "The Cost of Unsafe Injections." Bulletin of the World Health Organization, vol. 77, no. 10, 1999, pp. 808-11.
Miller MA, Pisani E. The cost of unsafe injections. Bull World Health Organ. 1999;77(10):808-11.
Miller, M. A., & Pisani, E. (1999). The cost of unsafe injections. Bulletin of the World Health Organization, 77(10), 808-11.
Miller MA, Pisani E. The Cost of Unsafe Injections. Bull World Health Organ. 1999;77(10):808-11. PubMed PMID: 10593028.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The cost of unsafe injections. AU - Miller,M A, AU - Pisani,E, PY - 1999/12/11/pubmed PY - 1999/12/11/medline PY - 1999/12/11/entrez KW - Behavior KW - Biology KW - Cost Benefit Analysis KW - Delivery Of Health Care KW - Diseases KW - Equipment And Supplies KW - Evaluation KW - Health KW - Health Services KW - Hepatitis--transmission KW - Hiv Infections--transmission KW - Immunization KW - Primary Health Care KW - Quantitative Evaluation KW - Risk Behavior KW - Risk Factors KW - Risk Reduction Behavior KW - Summary Report KW - Syringe KW - Viral Diseases SP - 808 EP - 11 JF - Bulletin of the World Health Organization JO - Bull World Health Organ VL - 77 IS - 10 N2 - Unsafe injection practices are associated with substantial morbidity and mortality, particularly from hepatitis B and C and human immunodeficiency virus (HIV) infections. These inadvertently transmitted bloodborne diseases become manifest some considerable time after infection and hence may not be appropriately accounted for. Annually more than 1.3 million deaths and US$ 535 million are estimated to be due to current unsafe injection practices. With the global increase in the number of injections for vaccination and medical services, safer injecting technologies such as auto-disable syringes must be budgeted for. Investment in health education and safer disposal will also reduce infections associated with unsafe injecting practices. Safer injecting practices are more expensive than current less safe practices, but the additional cost is more than offset by the reduction in disease that would result. SN - 0042-9686 UR - https://www.unboundmedicine.com/medline/citation/10593028/The_cost_of_unsafe_injections_ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10593028/ DB - PRIME DP - Unbound Medicine ER -